9th Annual Biomarkers Congress

Drug Design: Vertex Pharmaceuticals

Total Score People Score Events Score
11 8 9
Date Event Presentation Speakers
April 28, 2010 HCV Drug Discovery KEYNOTE Telaprevir: Discovery, Homologues and Clinical Update Youssef Bennani
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Proactive Risk Communication as Key to Public Health and Pharmaceutical Risk Benefit Management Strategy Cherif Benattia
October 21, 2008 Ion Channels as therapeutic targets Sodium Channel Blockers and Pain Mechanisms Jesus Tito Gonzalez
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 13: HCV Key Viral Proteins, Drug Targets and the Corresponding Antiviral Therapeutics (Part II) Recent Clinical Trial Results with Host- and Specifically-Targeted Antiviral Therapies for HCV (STAT-C) Ann D Kwong
Review talk: The Genetic and Structural Basis of HCV Resistance to STAT-C Inhibitors Chao Lin
HCV Protease Inhibitors-2: Update of Linear Peptidomimetic Inhibitor Clinical Trial Results Tara Kieffer
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) POTASSIUM CHANNELS AND DISEASE (14:10-15:45) Jesus Tito Gonzalez
POTASSIUM CHANNELS AND DISEASE: Chairperson’s Remarks (14:10-14:15) Jesus Tito Gonzalez
TECHNOLOGIES FOR ION CHANNEL DRUG DISCOVERY (09:40-12:25) Jesus Tito Gonzalez
TECHNOLOGIES FOR ION CHANNEL DRUG DISCOVERY: Probing Voltage-gated Channels in Neurons (11:25-11:55) Jesus Tito Gonzalez
October 16, 2007 Inaugural Kinbase Inhibitors: Moving Forward into Clinical Studies Oct (16-17) Executive Panel: Delivering Drugs for Difficult Targets (08:40-09:40) Jesus Tito Gonzalez
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) Keynote Introduction; Executive Panel: Delivering Drugs for Difficult Targets (08:40-09:40) Jesus Tito Gonzalez
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Mark Murcko
PROFILING TO OPTIMIZE EFFICACY: The Wisdom of Crowds versus the Inevitability of Black Swans: What we Can and Cannot Learn from History (08:35-09:15) Mark Murcko
PROFILING TO OPTIMIZE EFFICACY (08:30-14:00) Mark Murcko
PROFILING TO OPTIMIZE EFFICACY: Panel Discussion - The Value of Doing Systems Biology after HTS (12:15-12:45) Mark Murcko
PROFILING TO OPTIMIZE EFFICACY: Chairperson’s Remarks (08:30-08:35) Mark Murcko
September 27, 2007 Protein Expression Europe (Sep 27-28) Breakfast BuzZ Sessions (08:00-09:00) Joanna Long
Breakfast BuzZ Session VII: Insect Cell Expression—Working the “Bugs” Out (08:00-09:00) Joanna Long
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.